Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot ...

A large meta-analysis of over 20,000 people found that modern genetic testing can identify a clinically meaningful cause of schizoprenia in about 1 in 16 patients (6%), especially in early-onset ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

More and more scientists are taking advantage of DNA microarray chip technology to further their research. PubMed can give a rough estimate of the growth and acceptance of this technology; a search ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

A cheap home DNA kit seemed like a bit of fun – until the results exposed hidden ancestry and a family secret no one had prepared for.

A long-running experiment in serial mouse cloning has produced a sharp scientific reversal. A 2013 peer-reviewed report ...

Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

All the news that moves the needle in pharma and biotech Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters. Receive The Pharma ...

Agilent’s Microarray Hybridization Oven was designed for optimal hybridization performance and ultimately, consistently reliable data. With advanced features including variable and adjustable ...

Newcastle University and Procter & Gamble (P&G) are marking over 10 years of partnership with a new report showcasing their shared achievements and future goals.